Menu Menu

News

Featured
COVID-19 Research Pipeline

146,236

Registered/ Published

4,341

Registered

672

Published

6,231

Registered
As at 01 July 2022
FILTERED BY > Mild COVID-19 Clear filter

I have mild COVID – should I take the antiviral Paxlovid?

30 May, 2022
How effective is Paxlovid in treating mild COVID-19? Taskforce Director, Tari Turner, together with Primary Chronic Care Co-Chairs Nicole Allard and Mark Morgan and Disease-Modifying Treatments & Chemoprophylaxis Panel Members Amanda Gwee and Jason Roberts, explain the effectiveness, risk factors and accessibility of Paxlovid for people with mild COVID-19 in The Conversation.
News

Communique #62

31 March, 2022
Click for the latest Taskforce news:   
Communique

I’ve tested positive for COVID-19? What treatments are available?

9 March, 2022
  With several new drug treatments for people with mild COVID-19 now available, it can be tricky to know what your options are should you test positive to...
Explainer

Communique #59

7 March, 2022
Click for the latest Taskforce news:
Communique

Communique #58

18 February, 2022
Click for the latest Taskforce news:
Communique

Communique #56

31 January, 2022
Click for the latest Taskforce news:
Communique

Communique #52

29 October, 2021
Click for the latest Taskforce news:
Communique

Weekly Communique #3

30 April, 2020
WEEK IN REVIEW We welcomed the following new members to the Taskforce: College for Emergency Nursing Australasia (CENA) Royal Australian and New Zealand College of Obstetrics and Gynaecology...
Communique

Weekly Communique #1

16 April, 2020
In the midst of another whirlwind week for all of us, it has been encouraging to see the substantial progress of the Taskforce, and also to feel an...
Communique